ACTU vs MGX
Comparison between Actuate Therapeutics Inc (ACTU, Company) and Metagenomi Inc (MGX, Company).
Both ACTU and MGX are from the Healthcare sector.
ACTU vs MGX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
ACTU
$46M
Winner
MGX
$46M
Max Drawdown
Winner
ACTU
85.55%
MGX
90.20%
Sharpe Ratio
ACTU
-1.23
Winner
MGX
-0.00
5Y Beta
ACTU
N/A
MGX
1.00
Industry
ACTU
Biotechnology
MGX
Biotechnology
P/E Ratio
Winner
ACTU
-2.04
MGX
-0.54
PEG Ratio
ACTU
N/A
MGX
-0.06
Debt to Equity
ACTU
0.00%
MGX
0.00%
Free Cash Flow Yield
ACTU
-42.40%
MGX
N/A
P/S Ratio
ACTU
N/A
MGX
2.07
P/B Ratio
ACTU
N/A
MGX
0.34
ACTU vs MGX - Historical Returns
Returns include dividend reinvestment.
1M
ACTU
-30.10%
Winner
MGX
-11.11%
3M
Winner
ACTU
-20.78%
MGX
-23.57%
6M
ACTU
-73.14%
Winner
MGX
-27.27%
1Y
ACTU
-76.54%
Winner
MGX
-17.24%
Max(CAGR)
Winner
ACTU
-54.74%
MGX
-60.14%
ACTU vs MGX - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | ACTU | MGX |
|---|---|---|
| 2026 | -66.50% | -28.14% |
| 2025 | -23.12% | -57.26% |
| 2024 | -7.55% | -64.99% |
ACTU vs MGX Drawdown Comparison
The maximum drawdown for ACTU was -85.55%, occurring on Apr 10, 2026. This drawdown has not yet recovered.
The maximum drawdown for MGX was -90.20%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The current ACTU drawdown is -83.03%. The current MGX drawdown is -90.20%.
| Rank | ACTU | MGX |
|---|---|---|
| #1 | -85.55% May 30, 2025 - Apr 10, 2026 | -90.20% Feb 14, 2024 - Jun 12, 2026 |
| #2 | -40.82% Jan 23, 2025 - May 30, 2025 | N/A |
| #3 | -36.61% Aug 14, 2024 - Oct 28, 2024 | N/A |
| #4 | -26.65% Oct 28, 2024 - Jan 21, 2025 | N/A |
Correlation
Correlation between ACTU and MGX is 0.51 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.51
-101
Select Stocks to Compare
Popular: ACTU vs SPYMGX vs SPY
More Comparisons
Compare with similar stocks